129 related articles for article (PubMed ID: 10525616)
1. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].
Bosch FX; Homann N; Conradt C; Dietz A; Erber R
HNO; 1999 Sep; 47(9):833-48. PubMed ID: 10525616
[No Abstract] [Full Text] [Related]
2. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
Koscielny S; V Eggeling F; Dahse R
Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
[TBL] [Abstract][Full Text] [Related]
3. [Examinations on the importance of the inactivation of the tumor suppressor gene p16, reactivation of the telomerase and mutation of p53 in the pathogenesis of head and neck tumors].
Koscielny S
Laryngorhinootologie; 2003 Mar; 82(3):197-8. PubMed ID: 12673521
[No Abstract] [Full Text] [Related]
4. [Prognostic factors in head-neck carcinomas].
Weber A; Tannapfel A
HNO; 2002 Jan; 50(1):35-42. PubMed ID: 11963785
[TBL] [Abstract][Full Text] [Related]
5. [Overexpression of p53 as prognosis factor in vulvar carcinoma].
Kohlberger P; Breitenecker G; Gitsch G; Sliutz G; Kölbl H; Tschachler E; Reinthaller A; Kainz C
Gynakol Geburtshilfliche Rundsch; 1996; 36(1):40-1. PubMed ID: 8737523
[TBL] [Abstract][Full Text] [Related]
6. [Improved prognostic assessment of head-neck carcinomas by new genetic markers].
Bockmühl U; Küchler I; Petersen I
HNO; 2000 Jun; 48(6):451-6. PubMed ID: 10929226
[TBL] [Abstract][Full Text] [Related]
7. [Influence of glutathione s-transferase and cytochrome p450 polymorphisms on prognosis of head and neck cancer].
Matthias C; Jahnke V; Fryer AA; Strange RC
Laryngorhinootologie; 2002 Jun; 81(6):406-12. PubMed ID: 12063626
[TBL] [Abstract][Full Text] [Related]
8. [Translational research in head and neck cancer. Biological characteristics and general aspects].
Dietz A; Wichmann G
HNO; 2011 Sep; 59(9):874-84. PubMed ID: 21861150
[TBL] [Abstract][Full Text] [Related]
9. Identification of epidermal growth factor receptor (EGFR) exon 20 single nucleotide polymorphism in Chinese squamous cell carcinoma of head and neck (SCCHN).
Jin T; Yu CX; Jin T; Yu CX; Lei DP; Liu DY; Xu FL; Lu YT; Pan XL
Acta Otolaryngol; 2009 Nov; 129(11):1306-12. PubMed ID: 19863329
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].
Kunz C; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
HNO; 2003 Oct; 51(10):800-5. PubMed ID: 14523533
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx--a multivariate analysis].
Jäckel MC; Sellmann L; Youssef S; Dorudian MA; Füzesi L
HNO; 2001 Mar; 49(3):204-11. PubMed ID: 11320623
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer].
Haas S; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
HNO; 1999 Sep; 47(9):777-86. PubMed ID: 10525606
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.
Rave-Fränk M; Tehrany N; Kitz J; Leu M; Weber HE; Burfeind P; Schliephake H; Canis M; Beissbarth T; Reichardt HM; Wolff HA
Strahlenther Onkol; 2016 Jan; 192(1):47-54. PubMed ID: 26374452
[TBL] [Abstract][Full Text] [Related]
15. The role of MAGEA2 in head and neck cancer.
Glazer CA; Smith IM; Bhan S; Sun W; Chang SS; Pattani KM; Westra W; Khan Z; Califano JA
Arch Otolaryngol Head Neck Surg; 2011 Mar; 137(3):286-93. PubMed ID: 21422315
[TBL] [Abstract][Full Text] [Related]
16. [Expression of tumor suppressor gene p53 and Rb in patients with epidermoid carcinoma of the head and neck].
Schipper JH; Kelker W
HNO; 1994 May; 42(5):270-4. PubMed ID: 8050915
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for head and neck cancer.
Gleich LL
Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
[TBL] [Abstract][Full Text] [Related]
18. [Expression and localization profile of tenascin in squamous cell carcinomas of the head and neck].
Herold-Mende C; Andl T; Laemmler F; Reisser C; Eichhorn S
HNO; 1999 Aug; 47(8):723-9. PubMed ID: 10506500
[TBL] [Abstract][Full Text] [Related]
19. Which is the single most important factor in deciding the management and determining the prognosis of head and neck cancer?
Ferlito A; Takes RP; Rinaldo A; Devaney KO
Eur Arch Otorhinolaryngol; 2010 Mar; 267(3):325-6. PubMed ID: 19823861
[No Abstract] [Full Text] [Related]
20. [Promising approaches of translational research in head and neck cancer].
Dietz A
HNO; 2011 Sep; 59(9):857-8. PubMed ID: 21892801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
